Status:
COMPLETED
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Hypertension
Eligibility:
All Genders
Brief Summary
The primary objective of this survey is to prospectively investigate safety and efficacy in patients with hypertension treated with telmisartan in proper use in medical practice over a long period
Eligibility Criteria
Inclusion
- Patients with hypertension
Exclusion
- Patients with the following conditions
- Patients with a history of hypersensitivity of this product
- Women in pregnancy (included the possibility of pregnancy)
- Patients with severe biliary obstructive disorders or severe hepatic insufficiency
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
6336 Patients enrolled
Trial Details
Trial ID
NCT02242838
Start Date
September 1 2003
Last Update
September 17 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.